InvestorsHub Logo
Followers 52
Posts 3345
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Wednesday, 03/15/2017 4:26:32 PM

Wednesday, March 15, 2017 4:26:32 PM

Post# of 3283
Slides on Evomela from Ligand's presentation at the ROTH Conference today
(Slide 17 and 18). Slide 18 shows the revenue increase from 0.9M to 5.9M to $9.4M. Looks impressive in a bar graph.

http://seekingalpha.com/article/4055529-ligand-pharmaceuticals-lgnd-presents-29th-annual-roth-conference?auth_param=mqj99:1ccj4ih:3b443e6180ddd4ed8f59559c8efff1bd&uprof=44&dr=1